BioCentury
ARTICLE | Clinical News

MORAb-004: Phase II started

August 13, 2012 7:00 AM UTC

Eisai disclosed in its 1Q12 earnings ending June 30 that it began a double-blind, placebo-controlled international Phase II trial to evaluate MORAb-004 in combination with gemcitabine and docetaxel in...